Woodstock Corp’s Harmony Biosciences HRMY Stock Holding History

Woodstock Corp’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-11,761	Closed	-$385K	–	168
2023 Q3	$385K	Buy	+11,761	New	+$408K	0.05%	130

Other funds holding HRMY

Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Woodstock Corp's HRMY Position: Q4 2023 in Review

Woodstock Corp sold out of Harmony Biosciences (HRMY) in Q4 2023, closing a stake of 11,761 shares — an estimated $385K sold.

Woodstock Corp first reported a position in HRMY in Q3 2023 and held it in 1 quarter. The position peaked at $385K in Q3 2023. 221 funds tracked by Wall St. Rank hold HRMY as of Q4 2023.

Woodstock Corp reported no remaining Harmony Biosciences position as of Q4 2023 after selling out during the quarter.
Woodstock Corp sold 11,761 Harmony Biosciences shares in Q4 2023, an estimated $385K.
Woodstock Corp first reported a position in Harmony Biosciences in Q3 2023 and held it in 1 quarter.
Woodstock Corp's Harmony Biosciences position peaked at $385K in Q3 2023.
221 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2023.

Based on Woodstock Corp's 13F filing for Q4 2023, filed 8 Jan 2024.